Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Uveal metastasis in 1111 patients: Interval to metastasis and overall survival based on timing of primary cancer diagnosis.

Welch RJ, Malik K, Mayro EL, Newman JH, Honig SE, Ang SM, Selzer EB, Acaba-Berrocal LA, McGarrey MP, Graf AE, Considine SP, Shields JA, Shields CL.

Saudi J Ophthalmol. 2019 Jul-Sep;33(3):229-237. doi: 10.1016/j.sjopt.2019.07.006. Epub 2019 Jul 25.

2.

Uveal Metastasis Based on Patient Sex in 2214 Tumors of 1111 Patients. A Comparison of Female Versus Male Clinical Features and Outcomes.

Welch RJ, Malik K, Considine SP, Acaba-Berrocal LA, Selzer EB, Newman JH, Shields JA, Shields CL.

Asia Pac J Ophthalmol (Phila). 2019 Jul-Aug;8(4):298-303. doi: 10.1097/APO.0000000000000247.

3.

Choroidal amelanotic tumours: clinical differentiation of benign from malignant lesions in 5586 cases.

Welch RJ, Newman JH, Honig SE, Mayro EL, McGarrey M, Graf AE, Selzer EB, Acaba-Berrocal LA, Considine SP, Malik K, Shields JA, Shields CL.

Br J Ophthalmol. 2020 Feb;104(2):194-201. doi: 10.1136/bjophthalmol-2018-313680. Epub 2019 Apr 25.

PMID:
31023712
4.

Uveal Metastasis: Clinical Features and Survival Outcome of 2214 Tumors in 1111 Patients Based on Primary Tumor Origin.

Shields CL, Welch RJ, Malik K, Acaba-Berrocal LA, Selzer EB, Newman JH, Mayro EL, Constantinescu AB, Spencer MA, McGarrey MP, Knapp AN, Graf AE, Altman AJ, Considine SP, Shields JA.

Middle East Afr J Ophthalmol. 2018 Apr-Jun;25(2):81-90. doi: 10.4103/meajo.MEAJO_6_18.

Supplemental Content

Loading ...
Support Center